Asset Acquisition Agreement In Relation to Guangda PharmaceuticalAsset Acquisition Agreement • April 16th, 2010 • Sinovac Biotech LTD • Pharmaceutical preparations
production and sales of human vaccine. Party B is also engaged in supporting the national reserve of pandemic influenza vaccines (H1N1 Influenza A). Party B intends to be assigned the Debtor’s aforesaid Real Estates, machinery and other assets that have been acquired by Party A through the judicial procedures for the purpose of production and storage of human vaccines.
